--2025/FY-- / 9.259B--
--2024/FY-- / 8.187B--
Mar 22, 20242023/FY7.703B / 8.380B--
Mar 23, 20232022/FY8.282B / 8.537B--
Mar 19, 20222021/FY8.254B / 9.065B--
CN Stock MarketDetailed Quotes
600422 KPC Pharmaceuticals, Inc.
- 17.33
- +0.74+4.46%
Not Open Dec 20 15:00 CST
13.12BMarket Cap29.42P/E (TTM)
17.63High16.45Low245.05KlotVolume16.57Open16.59Pre Close422.13MTurnover3.24%Turnover Ratio29.52P/E (Static)756.98MShares23.9152wk High2.37P/B13.12BFloat Cap11.9252wk Low18.25Limit Up756.98MShs Float25.73Historical High14.93Limit Down7.11%Amplitude-0.59Historical Low0.20Dividend TTM17.23Avg Price93.92KlotAsk1.15%Div YieldTTM100Lot Size144.03KlotBid
KPC Pharmaceuticals, Inc. Key Stats
KPC Pharmaceuticals, Inc. Q3 2024 Earnings Date
Currency：CNYOct 26, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | -- | 1.90B | -- |
+3.41% | |||
| EPS | -- | 0.21 | -- |
-- |
Analyst Rating
Dec 22, 2024
KPC Pharmaceuticals, Inc. Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
KPC Pharmaceuticals, Inc. Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
